miR-375 mediated acquired chemo-resistance in cervical cancer by facilitating EMT.

miR-375 mediated acquired chemo-resistance in cervical cancer by facilitating EMT.
复制标题

miR-375 通过促进 EMT 介导宫颈癌获得性化疗耐药

DOI:
10.1371/journal.pone.0109299
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Cheng X
Cheng X
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Shen Y;Zhou J;Li Y;Ye F;Wan X;Lu W;Xie X;Cheng X

文献摘要

参考文献

被引文献

相似文献

获得性耐药是癌症死亡的主要原因之一。越来越多的证据表明,miRNA和上皮-间质转化在癌症的化疗耐药性中起着关键作用。在这里,我们显示了宫颈癌中紫杉醇耐药与miR-375过表达和上皮-间质转化诱导的相关性。使用不同的宫颈癌细胞模型,我们发现紫杉醇瞬时诱导miR-375表达上调,增殖抑制,从上皮细胞向间质细胞表型转化,从而损害紫杉醇敏感性。miR-375的强制过表达可能通过直接靶向途径抑制Ecadherin的表达,从而导致紫杉醇耐药。结果表明,Ecadherin的再表达部分逆转了上皮-间充质转化表型和miR-375诱导的紫杉醇耐药。我们的研究结果表明紫杉醇诱导的miR-375过表达通过直接靶向Ecadherin促进上皮-间质转化过程,抑制增殖,从而导致宫颈癌细胞的化疗耐药性。逆转miR-375或Ecadherin的表达可能是克服宫颈癌化疗耐药性的一种新的治疗方法。
Acquired chemo-resistance is one of the key causal factors in cancer death. Emerging evidences suggest that miRNA and epithelial–mesenchymal transition play critical roles in the chemo-resistance in cancers. Here, we showed the association of paclitaxel-resistance with miR-375 over-expression and epithelial–mesenchymal transition inducement in cervical cancer. Using different cervical cancer cell models, we found that paclitaxel transiently induced up-regulation of miR-375 expression, proliferation inhibition, transition from epithelial to mesenchymal phenotype, and consequently impaired paclitaxel sensitivity. Forced over-expression of miR-375 may suppress Ecadherin expression by a directly targeting pathway, which led to paclitaxel resistance. Contrarily, re-expression of Ecadherin partly reversed epithelial–mesenchymal transition phenotype and miR-375 induced paclitaxel-resistance. Our findings suggest that paclitaxel-induced miR-375 over-expression facilitates epithelial–mesenchymal transition process via directly targeting Ecadherin, proliferation inhibition, and consequently results in chemo-resistance in cervical cancer cells. A reversion of miR-375 or Ecadherin expression may be a novel therapeutic approach for overcoming chemo-resistance in cervical cancer.
DOI: 10.1158/1078-0432.ccr-10-2325
发表时间: 2011-04-15
影响因子: 11.5
作者:
Rosano, Laura;Cianfrocca, Roberta;Bagnato, Anna
通讯作者: Bagnato, Anna
DOI: 10.1016/j.ejca.2008.10.026
发表时间: 2009-01-01
影响因子: 8.4
作者:
Eisenhauer, E. A.;Therasse, P.;Verweij, J.
通讯作者: Verweij, J.
DOI: 10.1038/onc.2012.128
发表时间: 2013-02-28
期刊: ONCOGENE
影响因子: 8
作者:
Ward, A.;Balwierz, A.;Sahin, Oe
通讯作者: Sahin, Oe
DOI: 10.1038/sj.bjc.6605561
发表时间: 2010-03-02
影响因子: 8.8
作者:
通讯作者: --
天然药物对 microRNA 的调节:化学预防和化疗研究的新兴领域。
DOI: 10.1007/s11095-010-0105-y
发表时间: 2010-06
影响因子: 3.7
作者:
Li, Yiwei;Kong, Dejuan;Wang, Zhiwei;Sarkar, Fazlul H.
通讯作者: Sarkar, Fazlul H.